Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: An ex vivo human placenta perfusion and in vitro studySabrina Kuoni, Ana Paula Simões‐Wüst, R. Steiner et al.|Biomedicine & Pharmacotherapy|2024Cited by 15